Advisers to the U.S. Food and Drug Administration are expected to discuss two key questions when they meet on Sept. 17 to consider a COVID-19 vaccine booster campaign this fall: Is protection from the initial shots waning, and will boosters help?
U.S. FDA vaccine advisers face thorny question: Are COVID-19 boosters needed?
Post a Comment